- Home
- GPRO vs CERT Comparison
GPRO vs CERT Comparison
Compare GPRO & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPRO
- CERT
- Stock Information
- Founded
- GPRO 2004
- CERT 2008
- Country
- GPRO United States
- CERT United States
- Employees
- GPRO N/A
- CERT N/A
- Industry
- GPRO Industrial Machinery/Components
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- GPRO Consumer Discretionary
- CERT Technology
- Exchange
- GPRO Nasdaq
- CERT Nasdaq
- Market Cap
- GPRO 193.5M
- CERT 1.9B
- IPO Year
- GPRO 2014
- CERT 2020
- Fundamental
- Price
- GPRO $1.10
- CERT $10.71
- Analyst Decision
- GPRO Hold
- CERT Buy
- Analyst Count
- GPRO 1
- CERT 7
- Target Price
- GPRO $1.50
- CERT $15.92
- AVG Volume (30 Days)
- GPRO 1.6M
- CERT 1.4M
- Earning Date
- GPRO 02-05-2025
- CERT 11-06-2024
- Dividend Yield
- GPRO N/A
- CERT N/A
- EPS Growth
- GPRO N/A
- CERT N/A
- EPS
- GPRO N/A
- CERT N/A
- Revenue
- GPRO $896,011,000.00
- CERT $372,797,000.00
- Revenue This Year
- GPRO N/A
- CERT $10.20
- Revenue Next Year
- GPRO N/A
- CERT $10.43
- P/E Ratio
- GPRO N/A
- CERT N/A
- Revenue Growth
- GPRO N/A
- CERT 5.62
- 52 Week Low
- GPRO $1.08
- CERT $9.41
- 52 Week High
- GPRO $3.58
- CERT $19.87
- Technical
- Relative Strength Index (RSI)
- GPRO 37.45
- CERT 45.72
- Support Level
- GPRO $1.21
- CERT $10.31
- Resistance Level
- GPRO $1.36
- CERT $11.77
- Average True Range (ATR)
- GPRO 0.06
- CERT 0.58
- MACD
- GPRO -0.01
- CERT -0.07
- Stochastic Oscillator
- GPRO 9.71
- CERT 26.32
About GPRO GoPro Inc.
GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts, drones and appliances. The company outsources a part of manufacturing to third parties in China. The company sells products across the world through its direct sales channel, which generates over half of total revenue, and indirectly through its distribution channel. The company has presence, including in the Americas, Europe, Middle East, Africa, and Asia-Pacific, with the Americas contributing over half of total revenue.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.